• ABA The American Bar Association (ABA) Section of Intellectual Property Law and Center for Continuing Legal Education will be offering a live webinar entitled "Therasense, Inc. v. Becton, Dickinson and Company: The Federal Circuit's New Standard for Materiality" on June 15, 2011 from 2:00 – 3:30 PM (Eastern).  Retired Federal Circuit Chief Judge Paul Michel will moderate a panel consisting of Rohit K. Singla of Munger Tolles & Olson, Bradford J. Badke of Ropes & Gray LLP, and Rachel Krevans of Morrison & Foerster LLP, who will discuss the new standard for proving materiality when inequitable conduct is alleged and the impact of the en banc Therasense decision on the parties, the U.S. Patent and Trademark Office, and the future of patent litigation.

    The registration fee for the webcast is $95 for Section of Intellectual Property Law members, $99 for government attorneys, $150 for ABA members, and $195 for the general public (for group fee options, please visit the event website).  Those interested in registering for the webinar, can do so here.

  • Calendar

    June 15, 2011 – Therasense, Inc. v. Becton, Dickinson and Company: The Federal Circuit's New Standard for Materiality (American Bar Association) – 2:00 – 3:30 PM (Eastern)

    June 17, 2011 – The Implications of Stanford v. Roche (Intellectual Property Owners Association) – 2:00 PM (ET)

    June 19-20, 2011 – IP Business Congress (Intellectual Asset Management magazine) – San Francisco, CA

    June 21, 2011 – The Impact of Therasence v. Becton on the Doctrine of Inequitable Conduct (LexisNexis) – New York, NY

    June 21-22, 2011 – 10th Annual Forum on Pharma Patent Lifecycles (C5) – London, England

    June 23, 2011 – Chemical Patent Practice Road Show: Prosecution and Litigation Strategies (American Intellectual Property Law Association) – Chicago, IL

    June 27-30, 2011 – BIO International Convention (Biotechnology Industry Organization) – Washington, DC

    June 29-30, 2011 – Pharmaceutical Portfolio & Product Life Cycle Management (SMi Group) – London, UK

    July 16-19, 2011 – 2011 Annual Meeting; The Nuts & Bolts of Patent Prosecution Practice; and 2011 Patent Practice Update (National Association of Patent Practitioners) – Las Vegas, NV

    July 18-19, 2011 – Hatch-Waxman Boot Camp*** (American Conference Institute) – San Diego, CA

    July 20-21, 2011 – Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions*** (American Conference Institute) – San Francisco, CA

    July 25-27, 2011 – Intensive Patent Law Seminar (Chisum Patent Academy) – Seattle, WA

    August 4-7, 2011 – 2011 Annual Meeting (American Bar Association) – Toronto, Ontario

    August 16-18, 2011 – The Bilski Impact: Procuring & Enforcing Software, Business Methods & Bioinformatics Patents (Patent Resources Group) – Alexandria, VA and Southfield, MI

    September 18-20, 2011 – Accelerating Intellectual Property and Innovation in South Africa (South African Department of Science and Technology) – Cape Town, South Africa

    ***Patent Docs is a media partner of this conference or CLE

  • IPO #2 The Intellectual Property Owners Association (IPO) will offer a one-hour webinar on "The Implications of Stanford v. Roche" on Friday, June 17, 2011 beginning at 2:00 PM (ET).  The IPO webinar will consider the contract terms at issue in the case and examine the impact of the opinion on the patent reform debate, including the first-to-file provision.  The panel includes Ned Israelsen pf Knobbe Martens Olson & Bear, LLP; Patent Docs author Dr. Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP; and Jon Soderstrom, the Managing Director of the Office of Cooperative Research at Yale University.  The registration fee for the webinar is $120 (government and academic rates are available upon request).  Those interested in registering for the webinar can do so here.

  • LexisNexis LexisNexis will be offering a luncheon and CLE presentation entitled: "The impact of Therasence v. Becton on the doctrine of inequitable conduct" on June 21, 2011 from 11:30-1:00 PM (EST) at the Midtown Executive Club in New York, NY.  The presentation will address the following topics:

    • Evolution of the inequitable conduct doctrine from cases of egregious misconduct to liability for lesser offenses,
    Therasense holding and tightened standards, and
    • Impact on patent prosecutors and litigators.

    Those interested in registering for the CLE can do so here.

  • Brochure_200 The American Bar Association (ABA) will be holding its 2011 Annual Meeting from August 4-7, 2011 in Toronto, Ontario.  During the Annual Meeting, various ABA sections and divisions will be offering more than 250 CLE programs, including the following programs that will be offered by the Intellectual Property Law section:

    • International Patent Litigation;
    • The Demise of Junk Science in the Calculation of Reasonable Royalties;
    • Is the World Ready for a New Form of IP Protection?
    • FTC Enforcement in the Evolving IP Marketplace;
    • Update from the USPTO; and
    • Passing the Puck: The Future of International Patent Law Harmonization.

    On Saturday, August 6th, Justice Marshall Rothstein of the Supreme Court of Canada will be the keynote speaker at the ABA IP Law section luncheon.  A schedule of programs and events being offered by the Section of Intellectual Property Law at the ABA Annual Meeting can be found here.  The registration fee for individual CLE programs ranges from $35 for government lawyers and judges to $90 for all other attendees.  An All-Access CLE Badge ranges from for $75 (law school member) to $950 (non-ABA members).  Additional information regarding registration fees can be found here.  Those interested in registering for the Annual Meeting can do so here.

  • PRG Patent Resources Group (PRG) will be holding three-day course entitled:  "The Bilski Impact: Procuring & Enforcing Software, Business Methods & Bioinformatics Patents" from August 16-18, 2011 in Alexandria, VA and Southfield, MI.  The course will address how best to claim, prosecute, and litigate software, business method, and bioinformatics inventions.  The course syllabus can be obtained here.  Claim styles and limitations designed to meet the somewhat unclear post-Bilski § 101 standards will be discussed.  Legal ethics in the context of duty of disclosure under 37 C.F.R. § 1.56 and USPTO conflict of interest issues will also be presented.  The registration fee for the course is $2,195.  Those interested in registering for the event can do so here.

  • Supreme Court Holds That Invalidity Must Be Proved by Clear and Convincing Evidence

        By Donald Zuhn

    Supreme Court Building #3 In the third patent decision to be issued by the Supreme Court in little more than a week, the Court in Microsoft Corp. v. i4i Limited Partnership held today that 35 U.S.C. § 282 requires an invalidity defense to be proved by clear and convincing evidence.  Justice Sotomayor delivered the opinion of the Court, and was joined by all but Justice Thomas (who concurred in the judgment) and Chief Justice Roberts (who took no part in the decision).  Justice Breyer authored a concurring opinion, in which he was joined by Justices Scalia and Alito.

    Justice Sotomayor begins by noting that Congress has charged the U.S. Patent and Trademark Office with the task of examining patent applications and issuing patents where "the applicant is entitled to a patent under the law" (35 U.S.C. § 131), and that Congress has set forth the prerequisites that the Office must evaluate in determining whether a patent should be issued.  The opinion also notes that a patent grants exclusive rights to the holder, including the exclusive right to use the claimed invention, which can be enforced by bringing a civil action for infringement.  An accused infringer may counter by asserting one of the defenses under 35 U.S.C. § 282, including that the patent is invalid (i.e., "never should have issued in the first place").  The opinion points out that in asserting an invalidity defense, the accused infringer "must contend with the first paragraph of §282, which provides that '[a] patent shall be presumed valid' and '[t]he burden of establishing invalidity . . . rest[s] on the party asserting such invalidity,'" and that under the Federal Circuit's reading of § 282, the presumption of validity can only be overcome by persuading the factfinder of the patent's invalidity by clear and convincing evidence.  Justice Sotomayor notes that in American Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F. 2d 1350 (Fed. Cir. 1984), Judge Rich — citing Radio Corp. of America v. Radio Engineering Laboratories, Inc. ("RCA"), 293 U. S. 1 (1934) — concluded that:

    [Section] 282 creates a presumption that a patent is valid and imposes the burden of proving invalidity on the attacker.  That burden is constant and never changes and is to convince the court of invalidity by clear evidence.

    In the case before the Court, i4i brought suit against Microsoft in 2007, asserting that Microsoft's manufacture and sale of Microsoft Word infringed i4i's patent to an improved method of editing computer documents.  Microsoft denied infringement and counterclaimed for a declaration of invalidity and unenforceability.  With regard to its invalidity defense, Microsoft contended that i4i's sale of the S4 software program rendered the asserted patent invalid under 35 U.S.C. § 102(b).  At trial, Microsoft objected to i4i's proposed instruction that Microsoft was required to prove invalidity by clear and convincing evidence because the S4 program had never been presented to the USPTO during prosecution of the asserted patent, and requested the following instruction:

    Microsoft's burden of proving invalidity and unenforceability is by clear and convincing evidence.  However, Microsoft's burden of proof with regard to its defense of invalidity based on prior art that the examiner did not review during the prosecution of the patent-in-suit is by preponderance of the evidence.

    The District Court rejected Microsoft's hybrid standard of proof and instructed the jury that "Microsoft has the burden of proving invalidity by clear and convincing evidence."  The jury found that Microsoft failed to prove invalidity and that Microsoft had willfully infringed the i4i patent.  The Federal Circuit affirmed, saying that it could discern no error in the jury instruction requiring Microsoft to prove invalidity by clear and convincing evidence.  In response to this affirmance, Microsoft petitioned for certiorari, contending that the proper standard for proving invalidity is preponderance of the evidence, and at the very least, that the preponderance of the evidence standard should apply when an invalidity defense rests on evidence that was never considered by the USPTO during examination of the asserted patent.

    Justice Sotomayor Justice Sotomayor (at left) first notes that "by its express terms, §282 establishes a presumption of patent validity, and it provides that a challenger must overcome that presumption to prevail on an invalidity defense," adding that "while the statute explicitly specifies the burden of proof, it includes no express articulation of the standard of proof."  Turning to the issue of standard of proof, the opinion points to RCA (cited by Judge Rich in American Hoist & Derrick Co.), in which Justice Cardozo explained that "there is a presumption of validity, a presumption not to be overthrown except by clear and cogent evidence," and added that "one otherwise an infringer who assails the validity of a patent fair upon its face bears a heavy burden of persuasion, and fails unless his evidence has more than a dubious preponderance."  Justice Sotomayor therefore concludes that:

    The common-law presumption [i.e., the pre-1952 Act presumption] . . . reflected the universal understanding that a preponderance standard of proof was too 'dubious' a basis to deem a patent invalid.  . . .  Thus, by the time Congress enacted §282 and declared that a patent is "presumed valid," the presumption of patent validity had long been a fixture of the common law.  According to its settled meaning, a defendant raising an invalidity defense bore "a heavy burden of persuasion," requiring proof of the defense by clear and convincing evidence.

    Although § 282 does not expressly specify a standard of proof, the opinion states that "[u]nder the general rule that a common-law term comes with its common-law meaning, we cannot conclude that Congress intended to 'drop' the heightened standard [of] proof from the presumption simply because §282 fails to reiterate it expressly."  Pointing again to RCA, Justice Sotomayor writes that the case "leaves no doubt that attached to the common-law presumption of patent validity was an expression as to its 'force,' that is, the standard of proof required to overcome it" (citation omitted).  Although Microsoft argued that the Court had applied a clear-and-convincing standard of proof in only two limited circumstances in its pre-1952 cases, Justice Sotomayor responds that:

    Squint as we may, we fail to see the qualifications that Microsoft purports to identify in our cases.  They certainly make no appearance in RCA's explanation of the presumption of patent validity.  . . .  Nor do they appear in any of our cases as express limitations on the application of the heightened standard of proof.

    As for Microsoft's argument that that a preponderance of the evidence standard should at least apply where the evidence before the factfinder was not before the USPTO during the examination process, the opinion states that "[t]he question remains, however, whether Congress has specified the applicable  standard of proof," and responds that "Congress did just that by codifying the common-law presumption of patent validity and, implicitly, the heightened standard of proof attached to it."  Justice Sotomayor notes that "[o]ur pre-1952 cases never adopted or endorsed the kind of fluctuating standard of proof that Microsoft envisions," adding that "the Court's statement [in RCA] that a 'dubious preponderance' will never suffice to sustain an invalidity defense, admitted of no apparent exceptions" (citation omitted).  In footnote 10, Justice Sotomayor points out the "impracticalities" of Microsoft's fluctuating standard of proof, observing that because an examiner has no duty to cite every reference considered, whether an examiner has considered a particular reference will often be "a question without a clear answer."

    Justice Breyer, who joined the Court's opinion, writes separately to "emphasiz[e] that in this area of law as in others the evidentiary standard of proof applies to questions of fact and not to questions of law."  He adds that "[w]here the ultimate question of patent validity turns on the correct answer to legal questions — what these subsidiary legal standards mean or how they apply to the facts as given — today's strict standard of proof has no application."  Looking to lower courts for help, Justice Breyer writes that "[b]y preventing the 'clear and convincing' standard from roaming outside its fact-related reservation, courts can increase the likelihood that discoveries or inventions will not receive legal protection where none is due."  Justice Thomas, while concurring with the Court's judgment, differs with the Court as to whether Congress' use of the phrase "[a] patent shall be presumed valid" codified a standard of proof.  He reaches the same outcome as the Court, however, because § 282 is silent as to the standard of proof.  As a result, Justice Thomas writes that § 282 did not alter the common-law rule, which he characterizes as a "heightened standard of proof set forth in Radio Corp. of America v. Radio Engineering Laboratories, Inc., 293 U. S. 1 (1934) — which has never been overruled by this Court or modified by Congress."

    Microsoft Corp. v. i4i Limited Partnership (2011)
    Opinion of the Court by Justice Sotomayor, joined by Justices Scalia, Kennedy, Ginsburg, Breyer, Alito, and Kagan;
    Concurring opinion by Justice Breyer, joined by Justices Scalia and Alito;
    Opinion concurring in the judgment by Justice Thomas;
    Chief Justice Roberts took no part in the consideration or decision of the case.

  • By Kevin E. Noonan

    An anonymous correspondent writes:

    48 hours ago, it looked like the Patent Reform Act was a done deal.  Today, it's not at all that clear.

    Tuesday afternoon, Harold Rogers (Chairman of the House Appropriations Committee) and Paul Ryan (Chairman of Budget) wrote a letter to Chairman Smith insisting on maintaining the power of these two committees to raid the Patent Office of its user fees.  [See "Patent Reform News Briefs," June 7, 2011.]  What isn't mentioned in the letter is that Chairman Rogers was one of the main architects of fee diversion in the early part of the decade.

    Wednesday, four senior members of the Appropriations Committee reiterated their preference for fee diversion.

    It can be expected that almost all stakeholders will come out in opposition to the bill if the appropriators get their way.

    On Wednesday afternoon, in a debate between Robert Armitage (Eli Lilly) and Steven Miller (Proctor & Gamble) as proponents of the bill, against Pat Choate (an economist) and Jonathan S. Massey of Massey & Gail (a former Supreme Court clerk) in opposition to the bill, reports are that audience members came away with the realization that the bill raises real questions, that it may indeed be harmful to companies outside the Fortune 100, that the opponents of the bill have valid concerns, and that constitutionality of some provisions is certainly sufficiently questionable to create commercial uncertainty.

    In a third letter, Rep. Adam Schiff [D-CA] joined other legislators that have expressed concerns with several provisions of the bill.

    One knowledgeable source (who wished not to be identified) expressed the opinion at the end of the day Wednesday that the bill was no longer a "done deal," that its passage was truly an open question.

    Phone calls that seemed hopeless a week ago could now be decisive — the fate of the bill turns on about 5000 phone calls to representatives.

    Washington - Capitol #1 The letters in question raise legitimate questions.  As noted in an earlier Patent Docs post, Representatives Harold Rogers (R-KY) and Paul Ryan (R-WI) object to provisions of the House "patent reform" bill (H.R. 1249) by citing Constitutional concerns (transferring appropriation authority from Congress to the Executive) and partisanship (characterizing this change as being contrary to "the new Republican majority's commitment to restraining spending, improving accountability and transparency, and reducing the nation's unparalleled deficits and debt" and saying that "it would be both irresponsible and unwise to allow the PTO to operate solely under the authority of bureaucrats and White House political appointees," conveniently forgetting that the Bush White House ended fee diversion from 2004-2008).

    These sentiments were echoed (almost word-for-word) in a second letter from Rep. Rogers, joined by Representatives Frank Wolf (R-VA), Norman Dicks (D-WA), and Chaka Fattah (D-PA).

    Schiff, Adam On the other hand, Rep. Adam Schiff (R-CA) (at left) writes to oppose the "First to File" system set forth in Section 2 of the bill.  Rep. Schiff writes that this change will be "counterproductive" because it will hurt "the most creative inventors in our economy and lead to rushed patent filings."  In support of this proposition, he notes that "[t]he driving force of innovation comes from small, agile firms that marshal creative energies in exciting and productive ways" and that "[i]t is precisely these small firms" that will be hurt by this change, in his opinion.  Rep. Schiff cites the need for such small companies "to do additional market research, talk to venture capitalists or investors, develop their idea further and a myriad of other necessities" that the current system permits and a "first to file" regime will inhibit.  He also ties the need for outside patent counsel to prepare applications that will ultimately be discarded as a misuse of resources that would otherwise be used for "hiring and actual act[s] of invention."

    Artful lobbying and crafty politics (as well as a genuine belief that "patent reform" is necessary to address the backlog and other perceived weaknesses in the patent system) have gotten us to this moment.  Whether sufficient political opposition can be mounted to prevent passage of H.R. 1249 is an open question, one that will only be answered if enough stakeholders who think the bill is fundamentally flawed exercise their franchise and let their Representative know.  The time (once again) is now.

  • By Donald Zuhn

    House Issues Report on America Invents Act

    House of Representatives Seal On June 1, the House Committee on the Judiciary issued its report on H.R. 1249, the America Invents Act.  The 165-page report indicates that following consideration of the bill, the Committee now "reports favorably thereon with an amendment and recommends that the bill as amended do pass."  The report is divided into sixteen sections, including discussions of the amendment to the bill, the bill's purpose and summary, background and need for the legislation, agency views, dissenting views, and additional views.  Patent Docs intends to provide a more comprehensive analysis of the report in future posts.


    Rep. Manzullo Urges House Leaders to Shelve "Patent Reform" Bill

    Manzullo, Donald On Monday, Rep. Don Manzullo (R-IL) (at left) issued a press release calling on House leadership to "shelve" H.R. 1249, the "controversial 'patent reform' bill" that could make it to the floor for a vote as early as next week.  The impetus for Rep. Manzullo's request was the Supreme Court's decision in Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., which he says "upends the basic premise of the bill."  In particular, Rep. Manzullo points to the opinion's opening statement that "[s]ince 1790, the patent law has operated on the premise that rights in an invention belong to the inventor."  He also points to a subsequent statement by Chief Justice Roberts, the author of the opinion, that "[a]lthough much in intellectual property has changed in the 220 years since the first Patent Act, the basic idea that inventors have the right to patent their inventions has not."  Noting that the "main premise" of H.R. 1249 "is to switch America's patent system from a 'first to invent' system to a 'first to file' system," Rep. Manzullo contends that the "ruling by the Supreme Court affirms 'first to invent' and indicates HR 1249 would not pass constitutional muster."


    52 Representatives Seek Debate on Constitutionality of H.R. 1249

    Washington - Capitol #3 In a letter to Rep. David Dreier (R-CA), the Chairman of the House Committee on Rules, and Rep. Louise Slaughter (D-NY), the Ranking Member of the House Committee on Rules, 52 members of the House have requested that "any resolution reported by the Committee on Rules . . . to provide for consideration of H.R. 1249 include provision for a separate period of at least 20 minutes for debate on constitutionality of H.R. 1249 under clause 8 of Section 8 of Article I."  As most patent practitioners are aware, the clause of the Constitution cited in the legislators' letter confers upon Congress the power "To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries."

    In addition to Rep. Manzullo (R-IL), the other signatories to the letter include:  Representatives Michele Bachmann (R-MN), Tammy Baldwin (D-WI), Lou Barletta (R-PA), Roscoe Bartlett (R-MD), Dan Benishek (R-MI), Paul Broun (R-GA), Corinne Brown (D-FL), Mike Coffman (R-CO), Tom Cole (R-OK), John Conyers, Jr. (D-MI), Chip Cravaack (R-MN), Danny Davis (D-IL), Lloyd Doggett (D-TX), John Duncan, Jr. (R-TN), Donna Edwards (D-MD), Keith Ellison (D-MN), Marcia Fudge (D-OH), Charles Gonzales (D-TX), Walter Jones (R-NC), Marcy Kaptur (O-OH), Mike Kelly (R-PA), Steve King (R-IA), Dennis Kucinich (D-OH), John Lewis (O-GA), Daniel Lipinski (D-IL), Frank Lucas (R-OK), Jim McDermott (D-WA), Gregory Meeks (D-NY), Richard Neal (D-MA), Ed Pastor (D-AZ), Ron Paul (R-TX), Collin Peterson (D-MN), Thomas Petri (R-WI), Chellie Pingree (D-ME), Bill Posey (R-FL), Nick Rahall II (D-WV), Dana Rohrabacher (R-CA), Mike Ross (D-AR), Lucille Roybal-Allard (D-CA), Jon Runyan (R-NJ), Bobby Rush (D-IL), Robert Schilling (R-IL), Aaron Schock (R-IL), James F. Sensenbrenner, Jr. (R-WI), Brad Sherman (D-CA), Christopher Smith (R-NJ), Bennie Thompson (D-MS), Edolphus Towns (D-NY), Tim Walberg (R-MI), Allen West (R-FL), and Don Young (R-AK).  The letter was a bipartisan effort, with 26 Republicans and 26 Democrats requesting the period of debate.  Interestingly, two of the letter's signatories, Rep. Conyers and Rep. Sensenbrenner, Jr., are members of the House Judiciary Committee.


    House Appropriations and Budget Chairs Seek Changes to USPTO Funding Provision

    Rogers, Harold While some House members have begun to question the constitutionality of H.R. 1249 — or at least have expressed a desire to debate the issue — Rep. Harold Rogers (R-KY) (at right), the Chairman of the House Committee on Appropriations, and Rep. Paul Ryan (R-WI) (below), the Chairman of the House Committee on the Budget, have now raised concerns regarding the USPTO funding provision of the legislation.  In a letter sent on Monday to Rep. Lamar Smith (R-TX), the Chairman of the House Committee on the Judiciary, the two House Republicans state that H.R. 1249, which "is likely to be considered on the House floor in the upcoming weeks," would "permit the PTO to collect and spend authorized fees — all without requiring action or approval from Congress."

    Ryan, Paul Rep. Rogers and Ryan noted that they "strongly oppose this proposed shift of billions in discretionary funding and fee collections to mandatory spending," stating that "[p]utting PTO funding on auto-pilot is a move in exactly the wrong direction, given the new Republican majority's commitment to restraining spending, improving accountability and transparency, and reducing the nation's unparalleled deficits and debt."  The House Republicans add that "H.R. 1249 would also hand the Congressional 'power of the purse' — bestowed in the Constitution — to the Obama White House, and essentially eliminate the ability of Congress to perform substantive oversight of the PTO."  Asserting that "[o]versight of the PTO belongs with the Congress," the two legislators argue that "[i]t would be both irresponsible and unwise to allow the PTO to operate solely under the authority of bureaucrats and White House political appointees — without being held accountable to the American public through their elected Representatives in Congress."  The letter concludes by requesting that section 22 of H.R. 1249, which would create the U.S. Patent and Trademark Office Public Enterprise Fund to cover all USPTO administrative and operating expenses, be deleted or modified prior to floor consideration of the bill.


    Patent Reform Is Part of House Republican Jobs Plan

    Cantor, Eric Last week, House Majority Leader Eric Cantor (R-VA) (at right) announced the House Republican plan for job creation and economic growth.  A one-page summary of the plan indicated that entrepreneurship and growth would be encouraged by "[m]oderniz[ing] our patent system to protect our nation's innovators, discourage frivolous lawsuits, and expedite patent reviews."  The full jobs plan provided a bit more detail regarding this goal, characterizing the patent-related problem and the House Republicans' solution to that problem as follows:

    PROBLEM: PATENT BACKLOGS

    Our patent system protects American ideas and products.  It has historically been the envy of the world, but today it is failing to meet the challenges of the 21st Century.  Under our current patent system there is a backlog of 700,000 patent applications.  The current system of filing, challenging, and litigating patents can also lead to costly and unnecessary delays.

    REPUBLICAN SOLUTION

    We will modernize and improve the patent system to discourage frivolous lawsuits, expedite reviews, and provide better protection for job creating entrepreneurs.  Streamlining the system will make it easier for existing businesses to grow and allow more start-up companies to flourish.  The House Judiciary Committee voted to approve a bipartisan patent reform bill to address these challenges.

  • Supreme Court Sets Limits on the Bayh-Dole Act

        By Kevin E. Noonan

    Supreme Court Building #1 The Supreme Court today handed down its opinion in Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc.  The opinion begins (and could have ended) with a recitation of a fundamental premise of U.S. Patent Law:  "[s]ince 1790, the patent law has operated on the premise that rights in an invention belong to the inventor."  The question here, according to the Court, is whether Congress acted to overrule that principle for federally funded inventions under the Bayh-Dole Act and automatically vest title in the federal contractor.  The Court's opinion is that it does not.

    Stanford University The dispute arose when a research scientist at Stanford, who had signed (as part of his employment agreement) an agreement to assign to Stanford all federally funded inventions, performed research at Cetus and, as a condition for performing that work, signed an agreement to assign any inventions to the company.  This work resulted in methods for detecting HIV virus in patient samples, which are used to assess the effectiveness of AIDS treatments.  Stanford later obtained several patents on these inventions and sued Roche Molecular Systems (who had acquired Cetus) when the company marketed a diagnostic test that incorporated these methods.  The Federal Circuit below made a distinction between an "agreement to assign" to Stanford and the agreement to Cetus, which read that the scientists "will assign and hereby assigns" all inventions to the company.  For the appellate court, the language that the scientist "agreed to assign" to Stanford amounted to a promise to assign inventions not yet made and thus, under contract law, was insufficient to divest Cetus of title under the "will assign and hereby assigns" language of that agreement.

    Supreme Court Seal The Supreme Court affirmed, in an opinion by Chief Justice Roberts joined by all but Justices Breyer and Ginsberg (Justice Sotomayor filed a concurring opinion).  In doing so, the Court did not pass judgment on the Federal Circuit's interpretation of contract law, however, but focused on the preclusive effect, if any, of the Bayh-Dole Act on the inventor's interests in the invention.  The Court recited the several provisions of the Patent Act that require that an inventor is entitled to a patent (subject to the specific provisions of the Act; § 101); that the inventor must sign an oath or declaration attesting to inventorship (§ 115); and that a patent is issued to the inventor or the inventor's assignee (§§ 151, 152, and 261).  The primacy of the inventor as patentee is supported by precedent cited by the Court, including Gayler v. Wilder, 10 How. 477, 493 (1851); Solomons v. United States, 137 U.S. 342, 346 (1890); United States v. Dubilier Condenser Corp., 289 U.S. 178, 188 (1933), and under treaty, according to the Court.  While much of this same precedent supports the right of an inventor to assign rights to an invention to another, the patent right, ultimately, "must trace back to the inventor."  Mere employment is not enough to convey title to an invention from the employee to the employer, "unless there is an agreement to the contrary," and thus the issue before the Court was whether (or which of) the agreements was effective in transferring title.

    The Court characterizes the position taken by Stanford and the U.S. as amicus curiae, to be that Congress altered this traditional relationship regarding title to inventions made using monies from the Federal Government.  The Court rejected this view, saying that when Congress intended to do so in the past it had done so expressly.  The Court cited statutory provisions regarding nuclear energy (42 U.S.C. § 2182), NASA (51 U.S.C. § 20135(b)(1)) and the Department of Energy (42 U.S.C. § 5908) as examples of such express vesting of title of private patents to the U.S.  Such express language is "notably absent" from the Bayh-Dole Act, according to the Court, which stated that:

    Nowhere in the Act is title expressly vested in contractors or anyone else; nowhere in the Act are inventors expressly deprived of their interest in federally funded inventions.  Instead, the Act provides that contractors may "elect to retain title to any subject invention."  35 U. S. C. §202(a).

    The Court noted that, under § 201(e), "[a] 'subject invention' is defined as 'any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.'"  The Court explicitly rejected Stanford's reading of the phrase "invention of the contractor" to perform the vesting function, saying that to do so would "assume that Congress subtly set aside two centuries of patent law in a statutory definition" and would render the phrase "of the contractor" superfluous.  By this interpretation, the Act is limited to those inventions "owned by or belonging to the contractor," which would require assignment from the inventor to the university in order to be satisfied.  While noting that Stanford's reading of the phrase "the invention of the contractor" to mean "all inventions made by the contractor's employees is 'plausible in the abstract,'" the opinion expressly rejected the analogy with the products of other employees in other contexts (such as automobile manufacturing), saying that "patent law has always been different."  The Court rejected the idea that employment is enough, absent an agreement, to vest ownership of a patented invention.  The language of the Act specifying that the contractor can elect to retain title supports this view, in the Court's opinion, saying that "you cannot retain something unless you already have it," citing as an example Alaska v. United States, 545 U.S. 75, 104 (2005).  In the Court's opinion, "[t]he Bayh-Dole Act does not confer title to federally funded inventions on contractors or authorize contractors to unilaterally take title to those inventions; it simply assures contractors that they may keep title to whatever it is they already have."

    Roche The opinion contains two other important statements.  First (and in a footnote), the Court rejects the dissent's assertion that Executive Order 10096 acts to vest title in the government, saying that this Executive Order applies to federal employees, and that recipients of federally funded contracts are not federal employees.  Second, the Court rejected the interpretation that § 210 of the statute, which states that "it 'take[s] precedence over any other Act which would require a disposition of rights in subject inventions . . . that is inconsistent with' the Act" displaces the inventor's rights in favor of the university.  This can happen only with regard to "subject inventions," which the Court interprets to mean "inventions of the contractor," i.e., only after an inventor has assigned rights in the invention to the university.  This argument leads to the second statement:  the Court finds that the Act is limited to the "order of priority rights between the Federal Government and a federal contractor in a federally funded invention that already belongs to the contractor.  Nothing more."  The Court says that this interpretation is supported by the absence of any provisions regarding third parties "that have neither sought nor received federal funds" such as Roche.  The absence of such remedies "would be deeply troubling," according to the opinion, "[i]n a world in which there are frequent collaboration between private entities, inventors and federal contractors."  The opinion also states that Stanford's interpretation would vest title in inventions "even if the invention was conceived before the inventor became a University employee, so long as the invention's reduction to practice was supported by federal funding," and that title would vest in the university "even if only one dollar of federal funding was applied towards the invention's conception or reduction to practice."

    Finally, the opinion reviews other portions of the Act, such as § 202(d), which relate to the inventor "retaining" rights to the subject invention if the university declines to retain title.  The use of the word "retention" in the statute "would be odd," says the Court, if the inventor did not have rights in the invention to retain.

    Breyer, Justice Justice Breyer's (at right) dissent is based on his belief that the answer to the question presented to the Court "turns on matters that have not been fully briefed (and are not resolved by the opinion of the Court)."  In an opinion further supporting the Justice's role as this Court's Justice Douglas when it comes to patents (going so far as citing Heller and Eisenberg's discredited (by experience) "tragedy of the anticommons" article published more than a dozen years ago), the dissent sets forth a dichotomy.  On the one hand, the Justice writes, patents "help to elicit useful inventions and research and [] assure public disclosure of technological advances."  On the other hand, patents "sometimes mean unnecessarily high prices or restricted dissemination . . . [that] sometimes discourage further innovation and competition by requiring costly searches for earlier, related patents or by tying up ideas, which, were they free, would more effectively spur research and development."

    The dichotomy is given historical personification, between Jefferson discussing the "embarrassment of an exclusive patent" and Madison favoring a "'patent monopoly'" as "'compensation for' a 'community benefit.'"  Accordingly, the Justice is concerned about situations where the public must "pay twice" for inventions produced using federal funding.  In support of these concepts, he cites statutory provisions form before Bayh-Dole was enacted, which it should be recognized reflect a situation that the Act was intended (in part) to change, because it limited the capacity for publicly supported research to be commercialized.  Justice Breyer recognizes these pubic policy concerns — he states in his opinion that the desire to "encourage those institutions to commercialize inventions that otherwise might not realize their potentially beneficial public use" constitutes "a special public policy reason" expressly recited in the Act (§ 200).

    These concerns inform Justice Breyer's reticence to join the majority in permitting an inventor to assign an invention made using federal funds to a third party, "thereby taking that invention out from under the Bayh-Dole Act's restrictions, conditions, and allocation rules."  To do so would be "inconsistent with the Act's basic purposes" and could "significantly undercut the Act's ability to achieve its objectives."  The detriment to the public would be to permit a situation where an invention for which the public has paid would "avoid the Act's  . . . restrictions and conditions" and (paradoxically) "makes the commercialization and marketing of such an invention more difficult" due to questions about title like the ones raised in this case.

    Justice Breyer's dissent concentrates on the contract law interpretations of the Federal Circuit and, since he disagrees with them, would use that as the basis for reversing the decision below and remanding.  He notes that the Federal Circuit had relied upon an earlier opinion of that Court, FilmTec Corp. v. Allied-Signal, Inc., 939 F. 2d 1568 (1991), for the principle that "'[o]nce the invention is made and [the] application for [a] patent is filed, . . . legal title to the rights accruing thereunder would be in the assignee [i.e., Cetus] . . . , and the assignor-inventor would have nothing remaining to assign.'"  In Justice Breyer's opinion, this makes "too much of too little," since the scientist's agreement with Stanford "conveyed equitable, but not legal, title," and that under the circumstances of this case, equitable title would be all that the scientist could have conveyed to Cetus as well (relating to "present assignment of future inventions").  And "as between these two claims in equity," Justice Breyer would vest title in Stanford, because its equitable interest arose first and Stanford thereafter obtained express assignment of the inventions.

    In Justice Breyer's view, the FilmTec case was decided with "no explanation for what seems a significant change in the law" and its application to this case "undercuts the objectives of the Bayh-Dole Act."  Indeed, the Justice characterized the Federal Circuit's decision as producing "a technical trap for the unwary."

    Justice Breyer is careful to note that his views are 'tentative" because these issues were not briefed and were not the basis for the Court's decision.  However, although he doesn't believe the majority opinion "forecloses" these issues being raised by "similarly situated part[ies]" in a future case, since he believes they are important, he dissents.  Justice Sotomayor writes separately to concur because she, too, believes that these issues need to be considered when again properly raised.

    The real world consequences of the Court's decision today should be minimal, provided the Court is correct regarding the "common practice among parties operating under the Act."  These include policies to obtain assignments from inventor-employees and requirements (or at least expectations) from funding agencies that such assignments will be routinely obtained (the Court cited policy provisions promulgated by the NIH).  While this may be true, for university clients it is important to review such policies, not only to ensure they are in compliance with federal funding agency requirements but that university personnel (professors, students, and researchers) are aware of their obligations.  The Court's decision may not have, in fact, increased the burden on universities to protect these inventions, but it increases the vigilance that technology transfer offices and university officials must exercise in order to prevent loss of rights to third parties.  And it should not escape our notice that the Court's emphasis on the primacy of the inventor as a Constitutional limit on the powers of Congress in the exercise of the patent grant suggests that attempts to change U.S. Patent Law to a "first to file" system may not meet the standard set forth by the Supreme Court today.

    Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc. (2011)
    Opinion of the Court by Chief Justice Roberts, joined by Justices Scalia, Kennedy, Thomas, Alito, Sotomayor, and Kagan
    Concurring opinion by Justice Sotomayor
    Dissenting opinion by Justice Breyer, joined by Justice Gisburg